155 institutions hold shares in Avid Bioservices Inc. (CDMO), with 3.96M shares held by insiders accounting for 6.98% while institutional investors hold 67.78% of the company’s shares. The shares outstanding are 56.66M, and float is at 51.96M with Short Float at 4.24%. Institutions hold 63.05% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Blackrock Inc. with over 3.85 million shares valued at $44.38 million. The investor’s holdings represent 6.78% of the CDMO Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 2.75 million shares valued at $31.76 million to account for 4.85% of the shares outstanding. The other top investors are Snyder Capital Management, LP which holds 2.51 million shares representing 4.42% and valued at over $28.94 million, while Iszo Capital LP holds 4.19% of the shares totaling 2.38 million with a market value of $27.43 million.
Avid Bioservices Inc. (NASDAQ: CDMO) is 55.03% higher on its value in year-to-date trading and has touched a low of $3.02 and a high of $19.35 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDMO stock was last observed hovering at around $18.05 in the last trading session, with the day’s loss setting it -0.16% off its average median price target of $16.00 for the next 12 months. It is also 18.68% off the consensus price target high of $22.00 offered by 3 analysts, but current levels are -19.27% lower than the price target low of $15.00 for the same period.
Currently trading at $17.89, the stock is 5.51% and 27.00% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.09 million and changing -0.89% at the moment leaves the stock 96.65% off its SMA200. CDMO registered 159.28% gain for a year compared to 6-month gain of 114.51%. The firm has a 50-day simple moving average (SMA 50) of $15.59 and a 200-day simple moving average (SMA200) of $10.39.
The stock witnessed a 25.54% loss in the last 1 month and extending the period to 3 months gives it a 101.01%, and is -1.05% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.97% over the week and 6.38% over the month.
Avid Bioservices Inc. (CDMO) has around 222 employees, a market worth around $1.05B and $72.60M in sales. Fwd P/E is 255.57. Profit margin for the company is -6.80%. Distance from 52-week low is 492.38% and -7.55% from its 52-week high. The company has generated returns on investments over the last 12 months (-23.60%).
Avid Bioservices Inc. (CDMO) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Avid Bioservices Inc. (CDMO) is a “Buy”. 3 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Avid Bioservices Inc. is expected to release its quarterly report on 07/20/2021 and quarterly earnings per share for the current quarter are estimated at -$0.03 with sales reaching $19.07M over the same period.The EPS is expected to shrink by -54.60% this year, but quarterly earnings will post 44.50% year-over-year.
Avid Bioservices Inc. (CDMO) Insider Activity
A total of 1 insider transactions have happened at Avid Bioservices Inc. (CDMO) in the last six months, with sales accounting for 0 and purchases happening 1 times. The most recent transaction is an insider sale by Ziebell Mark R, the company’s V. P., General Counsel. SEC filings show that Ziebell Mark R sold 3,683 shares of the company’s common stock on Jul 13 at a price of $6.88 per share for a total of $25339.0. Following the sale, the insider now owns 6829.0 shares.
Avid Bioservices Inc. disclosed in a document filed with the SEC on Jul 13 that Hart Daniel R (Chief Financial Officer) sold a total of 2,056 shares of the company’s common stock. The trade occurred on Jul 13 and was made at $6.88 per share for $14145.0. Following the transaction, the insider now directly holds 17983.0 shares of the CDMO stock.
Still, SEC filings show that on Mar 23, Walsh Patrick D (Director) acquired 30,000 shares at an average price of $3.22 for $96600.0. The insider now directly holds 30,000 shares of Avid Bioservices Inc. (CDMO).